Logo image
Detection of Clenbuterol in Heroin Users in Twelve Postmortem Cases at the Philadelphia Medical Examiner's Office
Journal article   Open access   Peer reviewed

Detection of Clenbuterol in Heroin Users in Twelve Postmortem Cases at the Philadelphia Medical Examiner's Office

William E Wingert, Lisa A Mundy, Lauren Nelson, Stella C Wong and John Curtis
Journal of analytical toxicology, v 32(7), pp 522-528
Sep 2008
PMID: 18713522
url
https://doi.org/10.1093/jat/32.7.522View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

The presence of clenbuterol, a β2-adrenergic agonist banned for human use in the United States because of its serious side effects, is reported in a series of 12 postmortem cases in which the cause of death was attributed to illicit drug use. During the first three months of 2007, postmortem specimens from cases previously screening positive for opiates or fentanyl were screened specifically for clenbuterol using enzyme-linked immunosorbent assay. Confirmation of clenbuterol was performed using solid-phase extraction, derivatization with trimethylboroxine, and analysis utilizing a gas chromatograph-mass spectrometer (GC-MS) operated in the full-scan mode. The limits of detection and quantitation in blood were 2.5 and 5 ng/mL, respectively. Linearity was from 5 to 100 ng/mL. Clenbuterol was positive in 12/106 (11%) drug-related cases and in 12/575 (2.1%) of the total cases tested. In each of the 12 cases positive for clenbuterol, heroin use was either confirmed by the presence of 6-acetylmorphine or strongly suspected by the presence of morphine with a history of heroin abuse. Because the use of clenbuterol in the United States is restricted to veterinary medicine, its detection is an unexpected finding. Its presence in these cases serves as a caution to emergency room physicians and toxicologists to consider and test for clenbuterol when treating a suspected heroin user who presents atypically. This is the first known series of clenbuterol-positive cases of illicit drug users to be reported from a medical examiner's toxicology laboratory.

Metrics

9 Record Views
28 citations in Scopus
32 readers on Mendeley

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Chemistry, Analytical
Toxicology
Logo image